NextCell Pharma (Sweden) Probability of Future Stock Price Finishing Under 2.81
| NXTCL Stock | SEK 1.75 0.02 1.13% |
NextCell |
NextCell Pharma Target Price Odds to finish below 2.81
The tendency of NextCell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under kr 2.81 after 90 days |
| 1.75 | 90 days | 2.81 | close to 99 |
Based on a normal probability distribution, the odds of NextCell Pharma to stay under kr 2.81 after 90 days from now is close to 99 (This NextCell Pharma AB probability density function shows the probability of NextCell Stock to fall within a particular range of prices over 90 days) . Probability of NextCell Pharma AB price to stay between its current price of kr 1.75 and kr 2.81 at the end of the 90-day period is about 50.0 .
Assuming the 90 days trading horizon NextCell Pharma has a beta of 0.41. This indicates as returns on the market go up, NextCell Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NextCell Pharma AB will be expected to be much smaller as well. Additionally NextCell Pharma AB has an alpha of 0.5003, implying that it can generate a 0.5 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). NextCell Pharma Price Density |
| Price |
Predictive Modules for NextCell Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NextCell Pharma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NextCell Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NextCell Pharma is not an exception. The market had few large corrections towards the NextCell Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NextCell Pharma AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NextCell Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.50 | |
β | Beta against Dow Jones | 0.41 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | 0.11 |
NextCell Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NextCell Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NextCell Pharma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NextCell Pharma AB may become a speculative penny stock | |
| NextCell Pharma AB appears to be risky and price may revert if volatility continues | |
| NextCell Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M). | |
| NextCell Pharma AB has accumulated about 150.75 M in cash with (33.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company outstanding shares are owned by corporate insiders |
NextCell Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NextCell Stock often depends not only on the future outlook of the current and potential NextCell Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NextCell Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 34.4 M | |
| Cash And Short Term Investments | 97.1 M |
NextCell Pharma Technical Analysis
NextCell Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. NextCell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NextCell Pharma AB. In general, you should focus on analyzing NextCell Stock price patterns and their correlations with different microeconomic environments and drivers.
NextCell Pharma Predictive Forecast Models
NextCell Pharma's time-series forecasting models is one of many NextCell Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NextCell Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about NextCell Pharma AB
Checking the ongoing alerts about NextCell Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NextCell Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NextCell Pharma AB may become a speculative penny stock | |
| NextCell Pharma AB appears to be risky and price may revert if volatility continues | |
| NextCell Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.59 M. Net Loss for the year was (35.02 M) with loss before overhead, payroll, taxes, and interest of (2.49 M). | |
| NextCell Pharma AB has accumulated about 150.75 M in cash with (33.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.39, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company outstanding shares are owned by corporate insiders |
Additional Tools for NextCell Stock Analysis
When running NextCell Pharma's price analysis, check to measure NextCell Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NextCell Pharma is operating at the current time. Most of NextCell Pharma's value examination focuses on studying past and present price action to predict the probability of NextCell Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NextCell Pharma's price. Additionally, you may evaluate how the addition of NextCell Pharma to your portfolios can decrease your overall portfolio volatility.